108 BioCapital Invests $4 Million in SedMed to Support Commercial Growth
108 BioCapital has led a financing round for SedMed, Inc., investing $4 million. The funding will support the company's next phase of commercial growth and expand access to its non-electric toilet lift designed to assist older adults and individuals with mobility limitations. SedMed’s flagship product is an adjustable sit-to-stand aid that requires no electricity or bathroom modifications. The investment aims to accelerate distribution, strengthen partnerships, advance intellectual property, and conduct further hospital-based studies. SedMed's solution has already been adopted by over 40 hospital systems across the U.S., indicating strong market demand. The firm also sees international expansion potential in markets like India due to its non-electric design that is easy to deploy. The funding will help strengthen commercial reach and build evidence of value for healthcare organizations.
Topics: Investment Funding Medical Device Mobility Solutions